JP2013504075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013504075A5 JP2013504075A5 JP2012528396A JP2012528396A JP2013504075A5 JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5 JP 2012528396 A JP2012528396 A JP 2012528396A JP 2012528396 A JP2012528396 A JP 2012528396A JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- fgf
- multiple sclerosis
- anosmin
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200930661A ES2356540B1 (es) | 2009-09-07 | 2009-09-07 | Método para predecir las características histopatológicas de las lesiones de un sujeto con una enfermedad desmielinizante del sistema nervioso central. |
| ESP200930661 | 2009-09-07 | ||
| ESP201030090 | 2010-01-25 | ||
| ES201030090A ES2369099B1 (es) | 2010-01-25 | 2010-01-25 | La proteina Anosmina-1 como biomarcador para la clasificación histopatológica de lesiones de un sujeto con enfermedad desmielinizante del Sistema Nervioso Central. |
| PCT/ES2010/070584 WO2011045456A2 (es) | 2009-09-07 | 2010-09-07 | Nuevos biomarcadores de la histopatología de enfermedades desmielinizantes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013504075A JP2013504075A (ja) | 2013-02-04 |
| JP2013504075A5 true JP2013504075A5 (cg-RX-API-DMAC7.html) | 2013-10-24 |
Family
ID=43334531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528396A Pending JP2013504075A (ja) | 2009-09-07 | 2010-09-07 | 疾患組織病理の新規バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120252688A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2477030A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013504075A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010306515A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2773527A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011045456A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2762602B1 (fr) * | 1997-04-28 | 1999-06-04 | Inst Nat Sante Rech Med | Moyens pour la detection precoce de pathologies auto-immunes inflammatoires |
-
2010
- 2010-09-07 WO PCT/ES2010/070584 patent/WO2011045456A2/es not_active Ceased
- 2010-09-07 EP EP10763733A patent/EP2477030A2/en not_active Withdrawn
- 2010-09-07 CA CA2773527A patent/CA2773527A1/en not_active Abandoned
- 2010-09-07 US US13/394,501 patent/US20120252688A1/en not_active Abandoned
- 2010-09-07 AU AU2010306515A patent/AU2010306515A1/en not_active Abandoned
- 2010-09-07 JP JP2012528396A patent/JP2013504075A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Niu et al. | Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease | |
| JP5270684B2 (ja) | 脂肪肝疾患用のバイオマーカー及びその使用方法 | |
| Qiao et al. | Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection | |
| Meyer et al. | Targeted quantification of C-reactive protein and cystatin c and its variants by immuno-MALDI-MS | |
| Singh et al. | Non-invasive biomarkers for celiac disease | |
| CA3052349C (en) | Proadm as marker indicating an adverse event | |
| CN103403549B (zh) | 败血症的预后的预测方法 | |
| KR20160029869A (ko) | 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커 | |
| EP3497451A1 (en) | Histones and/or proadm as markers indicating an adverse event | |
| Molnar et al. | The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome | |
| EP3497450B1 (en) | Histones and/or proadm as markers indicating organ dysfunction | |
| JP2014525593A (ja) | 心臓血管リスクを予測するための診断分析 | |
| CN110702917B (zh) | 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途 | |
| Ren et al. | Recent advances in biomarkers for Parkinson’s disease focusing on biochemicals, omics and neuroimaging | |
| Singh et al. | Proteomic approaches to decipher mechanisms underlying pathogenesis in multiple sclerosis patients | |
| RU2013158667A (ru) | Способ диагностики болезни гоше | |
| WO2014018643A1 (en) | Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (tia) and peripheral arterial disease (pad) | |
| Kazamia et al. | Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms | |
| JP2016511407A5 (cg-RX-API-DMAC7.html) | ||
| JP2008538812A5 (cg-RX-API-DMAC7.html) | ||
| Pendyala et al. | Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease | |
| US10557860B2 (en) | Circulating pulmonary hypertension biomarker | |
| Dumitrache et al. | Evaluating the Discriminative Performance of Noninvasive Biomarkers in Chronic Hepatitis B/C, Alcoholic Cirrhosis, and Nonalcoholic Cirrhosis: A Comparative Analysis | |
| CN110988351B (zh) | 血管细胞黏附分子在制备抑郁症诊断治疗相关产品的用途 | |
| JP2013504075A5 (cg-RX-API-DMAC7.html) |